Abrams Bison Investments Buys 917,925 Shares in Teleflex

The investment firm now owns over 2% of the medical technology company's stock

Mar. 15, 2026 at 7:22am

Abrams Bison Investments LLC, a hedge fund, has purchased a new position of 917,925 shares in Teleflex Incorporated (NYSE:TFX), a medical technology company. The shares are valued at approximately $112.3 million, making Teleflex the fourth-largest holding in Abrams Bison's portfolio, accounting for 8.8% of the firm's total holdings.

Why it matters

This significant investment by Abrams Bison in Teleflex, a leading medical technology company, signals the hedge fund's confidence in the company's growth potential and future prospects. The purchase of over 2% of Teleflex's outstanding shares also makes Abrams Bison one of the company's largest institutional investors.

The details

According to Teleflex's most recent 13F filing with the SEC, Abrams Bison Investments LLC bought the 917,925 shares of Teleflex in the third quarter of the year. The purchase makes Teleflex the fourth-largest holding in Abrams Bison's portfolio, accounting for 8.8% of the firm's total investments.

  • Abrams Bison Investments LLC bought the 917,925 shares of Teleflex in the third quarter of 2026.

The players

Abrams Bison Investments LLC

A hedge fund that has purchased a new position of 917,925 shares in Teleflex Incorporated, making it one of the company's largest institutional investors.

Teleflex Incorporated

A medical technology company that produces a variety of devices and solutions used by healthcare professionals in hospital, ambulatory, and alternate site settings.

Got photos? Submit your photos here. ›

The takeaway

This significant investment by Abrams Bison in Teleflex, a leading medical technology company, signals the hedge fund's confidence in the company's growth potential and future prospects. The purchase of over 2% of Teleflex's outstanding shares also makes Abrams Bison one of the company's largest institutional investors, which could potentially influence the company's strategic direction and decision-making.